iSERA Lifesciences Files Monitoring Agency Report

iSERA Lifesciences Limited (formerly Covidh Technologies Limited) has filed a monitoring agency report for the quarter ended March 31, 2026, regarding the utilization of proceeds from its Rights Issue. The report, issued by Infomerics Valuation and Rating Private Limited, details the status of the utilization of issue proceeds as per Regulation 82 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report indicates no deviation from the stated objectives.